Maywood, Illinois 60153

  • Fusion of Spine

Purpose:

Postoperative ileus and opioid induced constipation are well-known post-operative complications. Previously, research has shown that using peripherally acting opioid antagonists can help alleviate the condition. There has not been a prospective study to investigate whether use of peripherally acting opioid antagonists are effective in preventing post-operative ileus in patients having spinal fusion surgeries.


Study summary:

Post operative ileus is a well-known complication following spinal fusion surgery. There has been some literature to demonstrate the safety and efficacy of oral naloxone to decrease the time to bowel movements after gastrointestinal surgery, to date, there have been no studies within the spine fusion literature to investigate oral naloxone's effects on the time to bowel movements. The aim of the present study is to use the previously established protocols and doses established in the gastrointestinal literature to see whether oral naloxone can decrease the time to first bowel movements.


Criteria:

Inclusion Criteria: - Patients will be included if they are having an in-patient spinal fusion procedure, are 18 years or older, post and post-operative pain control plan includes opioid medications. Exclusion Criteria: - Pregnancy, age < 18, nursing, or documented allergy to naloxone


NCT ID:

NCT03176316


Primary Contact:

Principal Investigator
Russell Nockels, MD
Loyola University

Kevin Swong, MD
Phone: 8158306957
Email: knswong@gmail.com


Backup Contact:

Email: johanssj@gmail.com
Stephen Johans, MD
Phone: 3147533049


Location Contact:

Maywood, Illinois 60153
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 18, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.